Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,207 | -7,886 | -24,204 | -19,314 | -12,032 |
| Depreciation Amortization | 28 | 20 | 73 | 55 | 37 |
| Accounts receivable | -6 | -11 | 32 | 46 | 30 |
| Other Working Capital | 647 | 87 | -525 | -75 | 376 |
| Other Operating Activity | 2,945 | 2,310 | 7,551 | 5,764 | 3,128 |
| Operating Cash Flow | $-8,593 | $-5,480 | $-17,073 | $-13,523 | $-8,462 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -35 | -18 | -16 | -13 |
| Investing Cash Flow | $-37 | $-35 | $-18 | $-16 | $-13 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,525 | 10,824 | 11,503 | 25 | 25 |
| Other Financing Activity | -913 | -911 | -381 | -30 | -20 |
| Financing Cash Flow | $11,612 | $9,913 | $11,122 | $-5 | $5 |
| Exchange Rate Effect | 387 | 162 | -590 | -218 | -484 |
| Beginning Cash Position | 15,469 | 15,611 | 21,886 | 22,198 | 22,109 |
| End Cash Position | 18,838 | 20,171 | 15,328 | 8,437 | 13,155 |
| Net Cash Flow | $3,369 | $4,560 | $-6,558 | $-13,761 | $-8,954 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,593 | -5,480 | -17,073 | -13,523 | -8,462 |
| Capital Expenditure | -37 | -35 | -18 | -16 | -13 |
| Free Cash Flow | -8,630 | -5,514 | -17,090 | -13,539 | -8,476 |